Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution

NCT02874846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Open Angle Glaucoma

Interventions

DRUG: Netarsudil ophthalmic solution 0.02%
OTHER: Netarsudil Ophthalmic Solution Vehicle

Sponsor

Aerie Pharmaceuticals